A database of FDA approved therapeutic peptides and proteins
| ID | ThPPID | Name | Peptide Sequence | Length | Functional Classification | Disease | Brand | Company | Physical Appearance | Route of Administartion | Category | Target |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1799 | Th1193 | Turoctocog alfa | NA Full view | 0 | Ia | Hematological Disorders | Zonovate | Novo Nordisk Canada Inc | sterile, non-pyrogenic, white or slightly yellow Powder | Intravenous | NA | NA |
| 1801 | Th1195 | Simoctocog Alfa | NA Full view | 0 | Ia | Hematological Disorders | Nuwiq | Octapharma Pharmazeutika Produktionsges M B H | Powder and solvent for Solution | Intravenous infusion | Antihaemorrhagics: blood coagulation factor VIII | NA |
| 1802 | Th1196 | Siltuximab | Heavy Chain Sequence Full view | 708 | IIa | Immunological Disorders | Sylvant | Janssen Inc | Lyophilized Powder | Intravenous infusion | Antineoplastic and Immunomodulating Agents, Immunosuppressive Agents | Interleukin-6 |
| 1809 | Th1200 | Prothrombin complex concentrate | NA Full view | 0 | Ia | Hematological Disorders | Octaplex | Octapharma | Powder and solvent for Solution | Intravenous | NA | NA |
| 1811 | Th1202 | Pembrolizumab | Heavy Chain Sequence Full view | 711 | IIIc | Cancer | Keytruda | Merck Sharp & Dohme Corp. | Lyophilized Powder | Intravenous infusion | Antineoplastic and Immunomodulating Agents | Programmed cell death protein 1 |
| 1817 | Th1208 | Metreleptin | MVPIQKVQDDTKTLIKTIVT Full view | 147 | Ib | Adjunct therapy | Myalept | Amylin Pharmaceuticals, LLC | Lyophilized Powder for Solution | Subcutaneous | Leptin receptor | |
| 1819 | Th1210 | Mepolizumab | NA Full view | 0 | Ib | Respiratory Disorder | Nucala | Glaxosmithkline Inc | Lyophilized Powder | Subcutaneous | Antineoplastic and Immunomodulating Agents, Immunosuppressive Agents, Interleukin Inhibitors | Interleukin-5 |
| 1831 | Th1221 | C1 Esterase Inhibitor (Recombinant) | NA Full view | 0 | IIa | Cardiac Disorders | Ruconest | Tjoapack Netherlands Bv | Powder and liquid for solution | Intravenous | Blood and Blood Forming Organs | Complement C1r subcomponent, Complement C1s subcomponent, Plasma kallikrein, Coagulation factor XII, Prothrombin, Coagulation factor XI, Tissue-type plasminogen activator |
| 1832 | Th1222 | Canakinumab | H-GAMMA-1 Chain: QVQ Full view | 842 | IIa | Immunological Disorders | Ilaris | Novartis | Lyphilized powder | Subcutaneous | Antineoplastic and Immunomodulating Agents | Interleukin-1 beta |
| 1835 | Th1224 | Chorionic Gonadotropin (Recombinant) | Alpha chain : APDVQD Full view | 237 | Ia | Hormonal Disorders | Ovitrelle | Merck Serono Europe Limited | powder and solvent to be made up into a solution | Subcutaneous | Hormones | Lutropin-choriogonadotropic hormone receptor, Follicle-stimulating hormone receptor |
| 1836 | Th1225 | Coagulation factor X human | NA Full view | 0 | Ib | Hematological Disorders | Coagadex | NA | powder and solvent used to make a solution | Intravenous | Blood Coagulation Factors | NA |
| 1838 | Th1227 | Efmoroctocog alfa | NA Full view | 0 | Ib | Hematological Disorders | ELOCTA | NA | Powder and solvent for solution for injection | Intravenous | Antihemophilic Factor | NA |
| 1839 | Th1228 | Factor IX Complex (Human) | NA Full view | 0 | Ib | Hematological Disorders | AlphaNine SD or Mononine | Powder and solvent for solution for injection | Intravenous | Antihemophilic agent | NA | |
| 1842 | Th1230 | Human Varicella-Zoster Immune Globulin | NA Full view | 0 | IIIa | Infectious Disease | VARIZIG | NA | lyophilized powder for solution | Intramuscular | Antibody | varicella zoster virus |
| 1846 | Th1234 | Protamine sulfate | NA Full view | 0 | Ib | Hematological Disorders | Protamine Sulfate Injection, USP | Omega Laboratories Ltd | off-white amorphous or crystalline powder | Intravenous | Heparin Antagonists, Hematologic Agents | NA |
| 1849 | Th1237 | Somatropin recombinant | FPTIPLSRLFDNAMLRAHRL Full view | 191 | Ib | Hormonal Disorders | BioTropin | Biotech General | Powder and Solvent for Solution | Subcutaneous | Hormones, Hormone Substitutes, and Hormone Antagonists | Growth hormone receptor, Prolactin receptor |
| 1851 | Th1238 | Susoctocog alfa | AIRRYYLGAVELSWDYRQSE Full view | 1448 | Ib | Hematological Disorders | Obizur | NA | Powder and solvent for solution for injection. | Intravenous | Blood coagulation factors, Antihaemorrhagics | von Willebrand factor |
| 1852 | Th1239 | Thrombomodulin Alfa | NA Full view | 0 | Ib | Hematological Disorders | Recomodulin (in Japan only) | Asahi Kasei Pharma Corp | lyophilized powder for solution | Intravenous | Anticoagulant agent, Antiplatelet agent | Prothrombin, Coagulation factor V |